Epigenetic inactivation and tumor suppressor activity of HAI‐2/SPINT2 in gastric cancer |
| |
| Authors: | Wenjie Dong Xiaobing Chen Jing Xie Pinghu Sun Yunlin Wu |
| |
| Affiliation: | 1. Department of Gastroenterology, Rui‐jin Hospital, Shanghai Jiao Tong University, Shanghai, China;2. Department of Medical Oncology, Henan Tumor Hospital, Zhengzhou, China;3. Department of Pathology, Rui‐jin Hospital, Shanghai Jiao Tong University, Shanghai, China;4. Fax: +86‐21‐64150773 |
| |
| Abstract: | Hepatocyte growth factor (HGF) activator inhibitor type 2 (HAI‐2/SPINT2) encodes Kunitz‐type protease inhibitor that regulates HGF activity. Inspection of the human HAI‐2/SPINT2 locus uncovered a large and dense CpG island within the 5′ region of this gene. Analysis of cultured human gastric tumor lines indicated that HAI‐2/SPINT2 expression is either undetectable or in low abundance in several lines; however, enhanced gene expression was measured in cells cultured on the DNA demethylating agent 5‐aza‐2′‐deoxycytidine. Bisulfite DNA sequencing confirmed the densely methylated HAI‐2/SPINT2 promoter region. Forced expression of HAI‐2/SPINT2 induced cell apoptosis, suppressed anchorage independent growth in vitro and tumor growth in vivo. We investigated HAI‐2/SPINT2 aberrant methylation in patients with gastric cancer. The HAI‐2/SPINT2 methylation was found preferentially in cancerous tissues (30 of 40, 75%) compared with nontumor tissues (no methylation was detected), indicating that this aberrant characteristic is common in gastric malignancies. In conclusion, epigenetic inactivation of HAI‐2/SPINT2 is a common event contributing to gastric carcinogenesis and may be a potential biomarker for gastric cancer. |
| |
| Keywords: | gastric cancer methylation HAI‐2/SPINT2 |
|
|
